BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

51 related articles for article (PubMed ID: 818838)

  • 1. [Effect of tolbutamide and glibenclamide on glucagon secretion in subjects with normal metabolism and in diabetics].
    Baumeister G; Zierden E; Wagner H; Stahl M
    Verh Dtsch Ges Inn Med; 1975; 81():1484-6. PubMed ID: 818838
    [No Abstract]   [Full Text] [Related]  

  • 2. [Clinical investigations of the effect of tolbutamide and glibenclamide on pancreatic glucagon secretion (author's transl)].
    Baumeister G; Wagner H; Stahl M
    Klin Wochenschr; 1975 Jun; 53(12):571-4. PubMed ID: 811925
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Suppression of glucagon secretion during a tolbutamide infusion in normal and noninsulin-dependent diabetic subjects.
    Pfeifer MA; Beard JC; Halter JB; Judzewitsch R; Best JD; Porte D
    J Clin Endocrinol Metab; 1983 Mar; 56(3):586-91. PubMed ID: 6337181
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacological comparison between tolbutamide and two second generation hypoglycemic sulfonylureas (glibenclamide and glisoxepide).
    Loubatiéres A; Mariani MM; Ribes G; Alric R
    Acta Diabetol Lat; 1973; 10(2):261-82. PubMed ID: 4200675
    [No Abstract]   [Full Text] [Related]  

  • 5. [The effect of tolbutamide and glibenclamide on HDL-cholesterol levels].
    Pados G
    Orv Hetil; 1982 Dec; 123(52):3195-6. PubMed ID: 6819506
    [No Abstract]   [Full Text] [Related]  

  • 6. K(ATP)-channels and glucose-regulated glucagon secretion.
    Rorsman P; Salehi SA; Abdulkader F; Braun M; MacDonald PE
    Trends Endocrinol Metab; 2008 Oct; 19(8):277-84. PubMed ID: 18771934
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Pharmacologic study with glisoxepide and other blood sugar reducing sulfonamide derivatives in metabolically healthy subjects and diabetics].
    Haupt E; Beyer J; Schöffling K
    Arzneimittelforschung; 1974 Mar; 24(0):418-25. PubMed ID: 4211557
    [No Abstract]   [Full Text] [Related]  

  • 8. [Betacytotropic and antilipolytic effect of critical doses of tolbutamide and glibenclamide].
    Rosak C; Haupt E; Bartelt KM; Beyer J; Schöffling K
    Verh Dtsch Ges Inn Med; 1972; 78():1278-81. PubMed ID: 4198781
    [No Abstract]   [Full Text] [Related]  

  • 9. [The behaviour of the serum insulin level in non obese adult diabetics after intravenous glucose, tolbutamide and glucagon].
    Lawecki J; Rogala H; Czyzyk A; Kowalski H
    Acta Diabetol Lat; 1970; 7(3):407-20. PubMed ID: 5515384
    [No Abstract]   [Full Text] [Related]  

  • 10. Modification of diuresis in the rat by chlorpropamide, glibenclamide and tolbutamide.
    Foy JM; Lucas PD
    Experientia; 1975 May; 31(5):570-3. PubMed ID: 237771
    [No Abstract]   [Full Text] [Related]  

  • 11. Observations of the mechanism of action of the sulfonylureas under clinical conditions.
    Jackson WP; Van Mieghem W; Keller P
    Metabolism; 1973 Sep; 22(9):1155-62. PubMed ID: 4199277
    [No Abstract]   [Full Text] [Related]  

  • 12. [Diabetes mellitus in adults and glibenclamide. Effects on lipid, protein, and carbohydrate metabolism in diabetics].
    León Castro J; Yáñez Polo MA; Sauret Valet J; De la Lama J
    Rev Clin Esp; 1971 Jan; 120(2):131-42. PubMed ID: 4998081
    [No Abstract]   [Full Text] [Related]  

  • 13. [Extrapancreatic effects of sulfonylurea compounds. IV. Increase of the effect of insulin due to tolbutamide, glibornuride, and glibenclamide in vitro].
    Beyer J; Gather W; Schöffling K
    Arzneimittelforschung; 1972 Dec; 22():Suppl 12A:2179. PubMed ID: 4198966
    [No Abstract]   [Full Text] [Related]  

  • 14. Influence of ranitidine on the hypoglycaemic activity of glibenclamide and tolbutamide in rabbits.
    Krishnaiah YS; Satyanarayana S; Visweswaram D
    Indian J Physiol Pharmacol; 1994 Oct; 38(4):316-8. PubMed ID: 7883304
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [What is the physiopathological importance of glucagon secretion?].
    Assan R; Tiengo A
    Journ Annu Diabetol Hotel Dieu; 1972; 13(0):109-18. PubMed ID: 4369711
    [No Abstract]   [Full Text] [Related]  

  • 16. Tolbutamide and glucagon secretion.
    Loubatières AL; Loubatiéres-Mariani MM; Alric R; Ribes G
    Diabetologia; 1974 Aug; 10(4):271-6. PubMed ID: 4607297
    [No Abstract]   [Full Text] [Related]  

  • 17. Modulation of A and B cell functions by tolbutamide and arginine in the pancreas of thiamine-deficient rats.
    Rathanaswami P; Sundaresan R
    Biochem Int; 1989 Oct; 19(4):793-802. PubMed ID: 2695088
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Glucagon and diabetes mellitus].
    Fussgänger RD
    Dtsch Med J; 1972 Oct; 23(10):601-8. PubMed ID: 4567113
    [No Abstract]   [Full Text] [Related]  

  • 19. Physiology of the pancreatic alpha-cell and glucagon secretion: role in glucose homeostasis and diabetes.
    Quesada I; Tudurí E; Ripoll C; Nadal A
    J Endocrinol; 2008 Oct; 199(1):5-19. PubMed ID: 18669612
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stimulation of biliary glutathione secretion by sulfonylureas.
    Patel TB; Rashed HM; Dyson J; Waller FM
    Mol Pharmacol; 1987 Jun; 31(6):638-42. PubMed ID: 3110590
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.